Subscribe
John Rosier explains why he remains optimistic on the market outlook
It鈥檚 good that this time the bull market may be different
John Baron explains why the portfolios鈥� healthcare exposure is being increased
TAA portfolio is boldly positioned for the big restart
Loser stocks have bounced back strongly recently. Don't expect them to continue to do so.
A manufacturer of beauty and healthcare products has delivered eye-popping results and looks primed to deliver in the new financial year, too.
Now it's time to be more circumspect when hunting through value stocks warns John Rosier
John Baron highlights the reasoning behind some recent changes to his portfolios that give them a more defensive bent
A litigation funding company has announced three major litigation finance agreements in the past seven weeks and is set to launch a follow-on third-party fund
A small-cap cash-rich technology group has made a complementary earnings-enhancing acquisition, and one that should help drive an eye-catching earnings recovery
